Dec 26 (Reuters) - Viracta Therapeutics Inc VIRX.O:
VIRACTA THERAPEUTICS ANNOUNCES CLOSURE OF NAVAL-1 CLINICAL TRIAL AND EXPLORATION OF STRATEGIC ALTERNATIVES
VIRACTA THERAPEUTICS INC - TO CLOSE PHASE 2 CLINICAL TRIAL OF NANA-VAL
VIRACTA THERAPEUTICS INC - CLOSURE OF TRIAL NOT DUE TO NEW SAFETY FINDING
VIRACTA THERAPEUTICS INC - POTENTIAL ALTERNATIVES INCLUDE MERGER, LICENSING AGREEMENT, SALE
Source text: ID:nGNXbcqMCQ
Further company coverage: VIRX.O
((Reuters.Briefs@thomsonreuters.com;))